Clinical Trial Update: A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of PF-08052667 in non-muscle invasive bladder cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• PF-08052667

Snippet

Sponsor: Pfizer | Conditions: Non-muscle Invasive Bladder Cancer | Phase 1 | Status: RECRUITING